Your browser doesn't support javascript.
loading
European Society of Cardiology: the 2023 Atlas of Cardiovascular Disease Statistics.
Timmis, Adam; Aboyans, Victor; Vardas, Panos; Townsend, Nick; Torbica, Aleksandra; Kavousi, Maryam; Boriani, Giuseppe; Huculeci, Radu; Kazakiewicz, Denis; Scherr, Daniel; Karagiannidis, Efstratios; Cvijic, Marta; Kaplon-Cieslicka, Agnieszka; Ignatiuk, Barbara; Raatikainen, Pekka; De Smedt, Delphine; Wood, Angela; Dudek, Dariusz; Van Belle, Eric; Weidinger, Franz.
Afiliação
  • Timmis A; The William Harvey Research Institute, Queen Mary University London, London E1 4NS, UK.
  • Aboyans V; Department of Cardiology, Dupuytren University Hospital, and EpiMaCT, Inserm 1098/IRD270, Limoges University, Limoges, France.
  • Vardas P; Biomedical Research Foundation Academy of Athens and Hygeia Hospitals Group, HHG, Athens, Greece.
  • Townsend N; European Society of Cardiology, European Heart Agency, European Heart Health Institute, Brussels, Belgium.
  • Torbica A; Centre for Exercise, Nutrition and Health Sciences, School for Policy Studies, University of Bristol, Bristol BS8 1TZ, UK.
  • Kavousi M; Centre for Research on Health and Social Care Management (CERGAS), Bocconi University, Milan, Italy.
  • Boriani G; Department of Epidemiology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Huculeci R; Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy.
  • Kazakiewicz D; European Society of Cardiology, European Heart Agency, European Heart Health Institute, Brussels, Belgium.
  • Scherr D; European Society of Cardiology, European Heart Agency, European Heart Health Institute, Brussels, Belgium.
  • Karagiannidis E; Division of Cardiology, Medical University of Graz, Graz, Austria.
  • Cvijic M; Second Department of Cardiology, General Hospital 'Hippokration', Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Kaplon-Cieslicka A; Department of Cardiology, University Medical Centre Ljubljana, and Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
  • Ignatiuk B; 1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
  • Raatikainen P; Department of Cardiology, Humanitas Gavazzeni University Hospital, Bergamo, Italy.
  • De Smedt D; Heart and Lung Center, Helsinki University Hospital, Helsinki, Finland.
  • Wood A; Department of Public Health and Primary Care, Ghent University, Ghent, Belgium.
  • Dudek D; Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Van Belle E; Instytut Kardiologii, Uniwersytet Jagiellonski, Collegium Medicum, Kraków, Poland.
  • Weidinger F; Cardiologie, Institut cœur-poumon, CHU de Lille, Lille, France.
Eur Heart J ; 2024 Aug 27.
Article em En | MEDLINE | ID: mdl-39189413
ABSTRACT
This report from the European Society of Cardiology (ESC) Atlas Project updates and expands upon the 2021 report in presenting cardiovascular disease (CVD) statistics for the ESC member countries. This paper examines inequalities in cardiovascular healthcare and outcomes in ESC member countries utilizing mortality and risk factor data from the World Health Organization and the Global Burden of Disease study with additional economic data from the World Bank. Cardiovascular healthcare data were collected by questionnaire circulated to the national cardiac societies of ESC member countries. Statistics pertaining to 2022, or latest available year, are presented. New material in this report includes contemporary estimates of the economic burden of CVD and mortality statistics for a range of CVD phenotypes. CVD accounts for 11% of the EU's total healthcare expenditure. It remains the most common cause of death in ESC member countries with over 3 million deaths per year. Proportionately more deaths from CVD occur in middle-income compared with high-income countries in both females (53% vs. 34%) and males (46% vs. 30%). Between 1990 and 2021, median age-standardized mortality rates (ASMRs) for CVD decreased by median >50% in high-income ESC member countries but in middle-income countries the median decrease was <12%. These inequalities between middle- and high-income ESC member countries likely reflect heterogeneous exposures to a range of environmental, socioeconomic, and clinical risk factors. The 2023 survey suggests that treatment factors may also contribute with middle-income countries reporting lower rates per million of percutaneous coronary intervention (1355 vs. 2330), transcatheter aortic valve implantation (4.0 vs. 153.4) and pacemaker implantation (147.0 vs. 831.9) compared with high-income countries. The ESC Atlas 2023 report shows continuing inequalities in the epidemiology and management of CVD between middle-income and high-income ESC member countries. These inequalities are exemplified by the changes in CVD ASMRs during the last 30 years. In the high-income ESC member countries, ASMRs have been in steep decline during this period but in the middle-income countries declines have been very small. There is now an important need for targeted action to reduce the burden of CVD, particularly in those countries where the burden is greatest.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article